Ubs Oconnor LLC Relay Therapeutics, Inc. Transaction History
Ubs Oconnor LLC
- $1.59 Billion
- Q1 2024
A detailed history of Ubs Oconnor LLC transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Ubs Oconnor LLC holds 100,039 shares of RLAY stock, worth $694,270. This represents 0.05% of its overall portfolio holdings.
Number of Shares
100,039Holding current value
$694,270% of portfolio
0.05%Shares
6 transactions
Others Institutions Holding RLAY
# of Institutions
187Shares Held
127MCall Options Held
4.2KPut Options Held
1.7K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$194 Million2.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$82 Million0.0% of portfolio
-
Black Rock Inc. New York, NY9.8MShares$68 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY7.42MShares$51.5 Million4.98% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.88MShares$47.7 Million0.01% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $834M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...